SCHEMBL1459947

SCHEMBL1459947

CC(C)(C)OC(=O)C1CC(B(O)O)=CCN1

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15566418 0.83
SCHEMBL513659 0.79 EPHX2 (0.35)
SCHEMBL8137468 0.75 MAPK1 (0.33) MAPK1
SCHEMBL7014119 0.74 MAPK1 (0.33) MAPK1
SCHEMBL8135029 0.71 GABRA1 (0.33) MAPK1
SCHEMBL16774517 0.70 MAPK1 (0.39) MAPK1
SCHEMBL16774516 0.70 MAPK1 (0.39) MAPK1
SCHEMBL6075300 0.70 PDK4 (0.30)
SCHEMBL29654701 0.70 P2RX7 (0.34) MAPK1
SCHEMBL6225316 0.70 MAPK1 (0.30) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3386511-A1 METHODS FOR TREATING HUNTINGTON'S DISEASE PTC Therapeutics, Inc. (US) 2018-10-17 EP disclosed
WO-2017100726-A1 METHODS FOR TREATNG HUNTINGTON'S DISEASE PTC THERAPEUTICS, INC. (US) 2017-06-15 WO disclosed
EP-2480529-A1 INDOLE DERIVATIVES AS CRAC MODULATORS F. Hoffmann-La Roche AG (CH) 2012-08-01 EP disclosed
WO-2011036130-A1 INDOLE DERIVATIVES AS CRAC MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2011-03-31 WO disclosed
WO-2010001166-A1 THIAZOLE DERIVATIVES AS GPR 119 MODULATORS PROSIDION LIMITED (GB) 2010-01-07 WO disclosed